CAHP Cardiac Arrest Hospital Prognosis Score
Clinical score predicting neurological outcome (CPC 1 or 2 at 30 days) in patients resuscitated from out-of-hospital cardiac arrest. Based on 8 variables at ED arrival. Validated in French multicentre cohorts. Low score indicates favourable neurological outcome.
Score interpretation
CAHP 150 or below — higher probability of good neurological outcome (CPC 1 or 2 at 30 days)
→ Continue post-cardiac arrest care; targeted temperature management (32 to 36 degrees C for 24 hours) if comatose after OHCA; coronary angiography if shockable rhythm or ischaemic aetiology suspected; frequent neurological assessment; avoid hypoxia (SpO2 94 to 98%), hypotension (MAP above 65), hyperthermia, and hyperglycaemia; EEG if seizure activity
CAHP above 150 — poor neurological outcome predicted at 30 days
→ Continue resuscitation care but initiate goals of care discussion; multimodal neuroprognostication required (EEG, CT or MRI brain, somatosensory evoked potentials, NSE) — do NOT withdraw treatment on CAHP score alone; wait at least 72 hours post-ROSC before prognostication; ethics and palliative care consultation if withdrawal of life-sustaining treatment is considered; senior intensivist and neurologist involvement; document all family discussions
Interpretation bands for the CAHP Score. Apply clinical judgement and local guidance.
References
- Maupain C et al. The CAHP (Cardiac Arrest Hospital Prognosis) score: a tool for risk stratification after out-of-hospital cardiac arrest. Eur Heart J. 2016;37(42):3204-3211.
Related
Curated clinical cross-links plus same-class fallbacks.
- Amiodarone (IV — ICU/Peri-Arrest) · Antiarrhythmic (Class III)
- Lidocaine IV (Cardiac Arrhythmia) · Antiarrhythmic
- Lisinopril (HFrEF / Post-MI) · ACE Inhibitor / HFrEF
- Colchicine (Pericarditis / Post-MI Inflammation) · Pericarditis / Coronary Inflammation
- Clopidogrel (ACS / Post-PCI) · Antiplatelet / ACS
- Protamine Sulphate (Heparin Reversal) · Heparin Reversal / Cardiac Surgery
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.